Literature DB >> 31534322

Sex-related differences in homebound advanced Parkinson's disease patients.

Lynda Nwabuobi1, William Barbosa2, Meghan Sweeney3, Sarah Oyler4, Talia Meisel5, Alessandro Di Rocco6, Joshua Chodosh7,8, Jori E Fleisher9.   

Abstract

BACKGROUND: Women with Parkinson's disease (PD) are more likely to be older, have greater disease severity and comorbidities, and yet are less likely to receive care from a neurologist, as compared with men with PD. Within the PD population, homebound individuals are a particularly vulnerable group facing significant barriers to care, yet within this understudied population, sex-related differences have not been reported.
PURPOSE: To identify and describe differences in homebound men and women with advanced PD and related disorders, participating in an interdisciplinary home visit program. PATIENTS AND METHODS: This was an exploratory analysis of homebound patients seen between February 2014 and July 2016 using data collected via in-person interviews and chart review.
RESULTS: We enrolled 85 patients, of whom 52% were women. PD was the most common diagnosis (79%), followed by dementia with Lewy bodies (5%), and other atypical parkinsonism (16%). Men were more likely to have a PD dementia diagnosis than women (17.1% vs 2.3%, p=0.03). Women were more likely to live alone (18.1% of women had no caregiver vs 2.4% of men, p=0.05).
CONCLUSION: The role of the caregiver in facilitating safe aging-in-place is crucial. Among homebound individuals with advanced PD, women were far more likely to live alone. The absence of a spouse or care partner may be due in part to variable sex-based life expectancies. Our findings suggest that homebound women with advanced PD may face greater barriers to accessing support.

Entities:  

Keywords:  aging; caregiver; gender disparities; health disparities; health services; parkinsonism

Mesh:

Year:  2019        PMID: 31534322      PMCID: PMC6681424          DOI: 10.2147/CIA.S203690

Source DB:  PubMed          Journal:  Clin Interv Aging        ISSN: 1176-9092            Impact factor:   4.458


Introduction

Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by both motor and nonmotor symptoms due to loss of dopaminergic neurons in the substantia nigra pars compacta. PD onset is likely from a complicated interplay between genetics and the environment.1 The prevalence of PD increases with age, rising from 41 cases per 100,000 at age 40–49 years to 1903 per 100,000 over age 80 years.2 As patients reach advanced stages of PD, gait, balance, and cognition are most notably affected and complications from dopaminergic therapy may become the focus of treatment.3,4 The combination of advanced PD, older age, and its associated accumulation of comorbidities are negatively reinforcing, rendering many people homebound. Once homebound and disconnected from routine care, this population is at further risk of deterioration and adverse events. Sex-related differences have been documented in several domains of PD, including clinical features, response to levodopa, non-motor symptoms, and quality of life, among others.5–9 Women are more likely to be older and have greater disease severity and more comorbidities than men despite similar PD duration.10 Women are less likely to be treated by a neurologist or receive surgical interventions like deep brain stimulation in the United States, despite evidence demonstrating the benefits of specialized care and interventions.9,11–13 A recent multicenter international cohort study of patients with PD also showed that women are at higher risk of poor access to caregivers.14 Given these findings of health-related disparities in women with PD in the outpatient setting, we hypothesized that homebound women with PD would be particularly vulnerable to poor care. To understand the interaction between homebound status, sex, and access to care, we conducted an exploratory analysis of baseline characteristics among homebound men and women enrolled in a home visit program (HVP) for individuals with advanced PD and related disorders.

Methods

Participants/setting

We recruited patients with advanced PD and related disorders into the Edmond J. Safra Interdisciplinary Home Visit Program for Advanced Parkinson’s Disease (HVP), which consisted of a movement disorders-trained neurologist, nurse, and social worker evaluating the patient at home every 4 months. We included patients if they had a diagnosis of PD or a related disorder provided by a referring movement disorders specialist, met Medicare homebound criteria, and lived within the five boroughs of New York City.15 Additionally, to be included, participants had to have one or more of the following risk factors for hospitalization or institutionalization: motor fluctuations, multi-morbidity, medication mismanagement, depression, anxiety, frequent hospitalizations, suspected elder abuse, caregiver burnout, or increased falls at home. Further details on the structure and processes of the HVP have been described elsewhere.16

Standard protocol approvals, registrations, and patient consents

The Institutional Review Board of New York University Langone Health approved this study.

Data collection

We conducted a retrospective, exploratory analysis of patients enrolled in the HVP from its inception in February 2014 to July 2016, including data collected via in-person interviews at the time of each initial home visit, and subsequent chart review. We de-identified and maintained all data in an electronic database – REDCap (Research Electronic Data Capture), a secure, web-based application designed to support data capture for research studies.17 We collected information on demographics, social factors, and clinical utilization. The Unified Parkinson’s Disease Rating Scale (UPDRS) and Hoehn & Yahr (H&Y) scores were documented based on examination by a movement disorders specialist during the visit.

Statistical analysis

We exported data to STATA 14 for analysis and used Chi-square and Fischer’s exact test to analyze differences between categorical variables. We used two-sample t-tests to analyze differences between continuous variables. Statistical significance was based on a two-tailed alpha of <0.05. Given the exploratory nature of the analysis, no corrections were made for multiple comparisons.

Results

Demographics

We enrolled 85 patients in the study. Patients received a median of three visits (range 1–7). Women comprised 52% of patients, as shown in Table 1. At visit 1, the median age of the group was 79.6 (range 43.3–93.9, standard deviation 8.7), with no significant sex-related differences (female 79.4 years, male 77.2 years, p=0.25). In terms of self-identified race, 7% each identified as African-American and Asian, respectively, and 15% identified as Hispanic. More women identified as Hispanic compared to men (22.7% vs 7.3%, p=0.07). Of the 49 individuals disclosing their educational attainment, 78% had a college degree or higher, with no significant difference between the sexes (p=0.99).
Table 1

Baseline demographics of homebound advanced PD patients

TotalMaleFemalep-value
Number of patients, n (%)85 (100)41 (48)44 (52)
Median age at visit 1, years79.677.279.40.41
Race, n (%)0.41
 White73 (85.9)33 (80.5)40 (90.0)
 Black6 (7.1)4 (9.8)2 (4.6)
 Asian6 (7.1)4 (9.8)2 (4.6)
Hispanic ethnicity, n (%)13 (15.3)3 (7.3)10 (22.7)0.07
College degree, n (%)38a (78)19 (79.1)19 (76.0)0.99
Marital status, n (%)<0.01
 Single11 (12.9)3 (7.3)8 (18.2)
 Partnered2 (2.4)2 (4.9)0 (0)
 Married41 (48.2)28 (68.3)13 (29.6)
 Divorced6 (7.1)3 (7.3)3 (6.8)
 Widowed25 (29.4)5 (12.2)20 (45.5)
Residence, n (%)0.87
 Independent dwelling77 (90.6)37 (90.2)40 (90.9)
 Assisted living3 (3.5)1 (2.4)2 (4.6)
 Nursing home5 (5.9)3 (7.3)2 (4.6)

Note: aNumber of 49 patients who reported educational attainment.

Baseline demographics of homebound advanced PD patients Note: aNumber of 49 patients who reported educational attainment.

Clinical characteristics

PD was the most common diagnosis among all the patients (79%), followed by dementia with Lewy bodies and progressive supranuclear palsy accounting for 5% each, multiple system atrophy2%, and other atypical parkinsonism 9% (Table 2). Men were more likely to have a PD dementia diagnosis than women (17.1% vs 2.3%, p=0.02). Among the patients with PD, men had a significantly higher mean total UPDRS score compared to women (85.6 vs 71.2, p<0.01). Baseline mean UPDRS-III (motor) score was 46.8 (SD 14.7). Men had more severe motor scores than women (49.9 vs 43.7, p=0.06). There was no significant sex-related difference in the Hoehn & Yahr (H&Y) stage (mean: men 4.1, women 3.9, p=0.22).
Table 2

Baseline clinical characteristics of homebound advanced PD patients

TotalMaleFemalep-value
Diagnosis, n (%)N=85N=41N=440.08
 Parkinson’s disease59 (69.4)27 (65.9)32 (72.7)
 Parkinson’s disease dementia8 (9.4)7 (17.1)1 (2.3)
 Dementia with Lewy bodies4 (4.7)2 (4.9)2 (4.5)
 Multiple system atrophy2 (2.4)1 (2.4)1 (2.3)
 Progressive supranuclear palsy4 (4.7)0 (0)4 (9.1)
 Corticobasal syndrome1 (1.2)0 (0)1 (2.3)
 Other atypical parkinsonism7 (8.2)4 (9.8)3 (6.8)
Disease severity
 UPDRS (total)85.671.2<0.01
 UPDRS-III49.943.70.06
 Hoehn & Yahr4.13.90.22
Inpatient utilization, n
 Hospitalizationsa0.680.480.23
 ED visitsa0.580.500.6
Outpatient utilization, n
 Neurology clinic visitsa2.462.480.97
 Missed clinic visitsa2.102.230.78
 Phone callsa,b12.1010.820.53
 Email communicationa,b1.071.520.60

Notes: aIn the past 12 months; bwith a movement disorders specialist.

Abbreviation: UPDRS, Unified Parkinson’s Disease Rating Scale.

Baseline clinical characteristics of homebound advanced PD patients Notes: aIn the past 12 months; bwith a movement disorders specialist. Abbreviation: UPDRS, Unified Parkinson’s Disease Rating Scale. Regarding access to health care, there were no significant sex-related differences in the number of hospitalizations or emergency department visits in the 12 months prior to the initial home visit (t-test, p=0.23, p=0.68, respectively). Similarly, we found no differences in outpatient utilization, specifically the number of attended outpatient neurology visits (p=0.97), missed visits (p=0.78), phone calls to the movement disorders specialist (t-test, p=0.53), or emails to the movement disorders specialist (p=0.60).

Social impact

We found significant sex-related differences in marital status, with a significantly higher proportion of women being widowed (45.5% vs 12.2%) or single (18.2% vs 7.3%) compared to men (p<0.01 for both) (Figure 1). Men were 2.3 times more likely to be married (68.3% vs 29.6%). As shown in Table 3, compared to men, women were less likely to have any caregiver present (18.1% of the women were alone vs 2.4% of the men, p<0.01). Comparing caregiver types, 70.7% of men identified a spouse, partner, or significant other serving as a caregiver compared to only 27.3% of women (p<0.01). There was no significant difference among those who identified an adult child (p=0.08), other family members (p=1.00), or a neighbor/friend (p=1.00) as their primary caregivers. Many subjects endorsed having home health aides (HHAs), with 48.2% having a part-time HHA and 21.2% having a full-time HHA, without statistically significant sex-related differences (p=0.10, p=0.43, respectively). Most visits were conducted in the home of the patient (90.6%) as opposed to an assisted living or skilled nursing facility (Table 1), and there were no sex-related differences in place of residence (p=0.87).
Figure 1

Partnerships and caregiver trends in homebound advanced PD patients.

Abbreviations: CG, caregiver; PD, Parkinson’s disease.

Table 3

Caregiver types and presence at visits

TotalMaleFemalep-value
Caregiver type, n (%)
 Spouse/partner41 (48.2)29 (70.7)12 (27.3)<0.01
 Adult child20 (23.5)6 (14.6)14 (31.8)0.08
 Other family member6 (7.1)3 (7.3)3 (6.8)1.00
 Friend3 (3.5)1 (2.4)2 (4.6)1.00
 Part-time home health aide41 (48.2)23 (56.1)18 (40.9)0.20
 Full-time home health aide18 (21.2)7 (17.1)11 (25)0.43
 No caregiver1 (1.18)0 (0)1 (2.27)1.00
Visits without caregiver, n (%)30 (11)3 (2.4)27 (18.1)<0.01
Caregiver types and presence at visits Partnerships and caregiver trends in homebound advanced PD patients. Abbreviations: CG, caregiver; PD, Parkinson’s disease.

Discussion

To our knowledge, ours is the first study to specifically explore the sex-related differences beyond disease progression in a homebound PD population. Despite the higher prevalence of PD in men in most studies conducted in outpatient settings, women comprised more than half of this homebound advanced PD group (44 women vs 41 men), and were more likely to be single or widowed, and to lack any caregiver.18 In the early phase of PD, women exhibit a milder disease phenotype and present at an older age compared to men. This may be possibly due to neuroprotective effects of estrogen.5,19,20 However, once the disease fully manifests, this slight advantage seen in women is no longer apparent.5 The longer life expectancy for women in the general population may explain the shift in distribution to an increasing prevalence of homebound women with advanced PD. As the disease progresses, women may be at increased risk for homebound status and hence, dependence on a caregiver and/or facility placement compared to men. This study showed that while a spouse or partner is the most likely individual to serve as a caregiver, homebound women were more likely to be single or widowed compared to men. They were also more likely to lack any caregiver. Hariz et al showed a similar finding in a group of PD patients who underwent pallidotomy, thalamotomy, or deep brain stimulation in which women were more likely to be living without a spouse (50% women vs 20% men).21 Dahodwala et al reported that women have fewer informal caregivers and were more likely to use formal caregivers compared to men, despite greater strain reported by caregivers of men with PD.14 Similarly, Fullard et al found that women used HHAs and skilled nursing facilities more than men and also had less outpatient physician contact compared to men.22 This suggests that women with advanced PD who are homebound are an especially vulnerable group due to a relative lack of caregivers/partners, and are therefore at risk of loss to follow up. Once neurologic follow-up is lost, these women may be at increased risk of hospitalizations, nursing facility placement, and poorer quality of life.11,23 A growing body of literature reports that women with PD are more likely to be institutionalized compared to men, possibly due to disparities in caregiver presence and type, or greater psychological distress, and institutionalization is associated with increased mortality.22,24–28 This further highlights the importance of caregivers in preventing premature institutionalization and excess mortality in women with PD. Men in this cohort had greater disease severity as evidenced by the higher mean total UPDRS score, and a higher rate of PD dementia. This is comparable to findings in other studies even after adjustment for age and disease duration.21,23,24,29–31 One explanation is that the equivalently impaired women either have been institutionalized or died rather than remain in the community, due to a lack of caregivers. These impairments also likely facilitate greater use of caregivers in men. Women historically play the role of caregiver, may have better symptom coping skills, and may not seek potentially helpful care. Lubomski et al demonstrated that women with PD are more likely to believe that they did not require support from an appointed caregiver.29 Education on the risks of poor continuity of care and the need to advocate for assistance may be an important intervention. Identifying patients at risk for homebound status creates an opportunity for clinicians to intervene, tailoring treatment strategies toward transition to said homebound status. The increased risk of homebound status among women and among individuals with severe disease should be discussed with these patients in advance so that they can identify and mobilize friends, family, and community resources for support in the future. A limitation of this study is that findings are from a convenience sample in New York and are not necessarily generalizable. Some of the observed differences or lack thereof could be attributable to access to the HVP itself. This study also focused primarily on the social impact of PD in the homebound patient and did not capture other measures that may contribute to sex-related differences in this population (eg, levodopa equivalent dose, disease duration, nonmotor symptoms, etc.). Future population-based studies that capture a larger sample of patients outside of an HVP setting will be useful to further evaluate and understand the observed sex differences and improve generalizability. A larger, ongoing adaptation of the HVP outside of New York, with matched controls, will start to answer these questions.

Conclusion

This study highlights the relative lack of caregivers among homebound women with advanced PD and emphasizes the vulnerability of this group of patients to interruptions in continuity of care. With additional understanding of barriers to care, clinicians can further individualize treatment strategies, counseling, and care planning based on these sex-related differences. Health systems opportunities to support individuals with PD are essential to improving care.
  28 in total

Review 1.  Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.

Authors:  J M Pavon; H E Whitson; M S Okun
Journal:  Maturitas       Date:  2010-02-01       Impact factor: 4.342

2.  Neurologist care in Parkinson disease: a utilization, outcomes, and survival study.

Authors:  A W Willis; M Schootman; B A Evanoff; J S Perlmutter; B A Racette
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  Gender differences in Parkinson's disease.

Authors:  Charlotte A Haaxma; Bastiaan R Bloem; George F Borm; Wim J G Oyen; Klaus L Leenders; Silvia Eshuis; Jan Booij; Dean E Dluzen; Martin W I M Horstink
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-10       Impact factor: 10.154

Review 5.  Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens.

Authors:  Glenda E Gillies; Simon McArthur
Journal:  Horm Behav       Date:  2009-06-16       Impact factor: 3.587

6.  Chronic conditions and the risk of long-term institutionalization among older people.

Authors:  Elina K Nihtilä; Pekka T Martikainen; Seppo V P Koskinen; Antti R Reunanen; Anja M Noro; Unto T Häkkinen
Journal:  Eur J Public Health       Date:  2007-06-11       Impact factor: 3.367

7.  Risk of Parkinson disease in women: effect of reproductive characteristics.

Authors:  P Ragonese; M D'Amelio; G Salemi; P Aridon; M Gammino; A Epifanio; L Morgante; G Savettieri
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

Review 8.  Gender differences in Parkinson's disease.

Authors:  Lisa M Shulman
Journal:  Gend Med       Date:  2007-03

9.  Are men at greater risk for Parkinson's disease than women?

Authors:  G F Wooten; L J Currie; V E Bovbjerg; J K Lee; J Patrie
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

10.  Gender differences in disability and health-related quality of life in patients with Parkinson's disease treated with stereotactic surgery.

Authors:  Gun-Marie Hariz; Margareta Lindberg; Marwan I Hariz; A Tommy Bergenheim
Journal:  Acta Neurol Scand       Date:  2003-07       Impact factor: 3.209

View more
  7 in total

Review 1.  Moving the Dial Toward Equity in Parkinson's Disease Clinical Research: a Review of Current Literature and Future Directions in Diversifying PD Clinical Trial Participation.

Authors:  Jennifer Adrissi; Jori Fleisher
Journal:  Curr Neurol Neurosci Rep       Date:  2022-06-17       Impact factor: 6.030

2.  Covid-19 and Parkinson's disease: Nursing care, vaccination and impact on advanced therapies.

Authors:  Anna Roszmann; Aleksandra M Podlewska; Yue Hui Lau; Iro Boura; Annette Hand
Journal:  Int Rev Neurobiol       Date:  2022-07-09       Impact factor: 4.280

3.  Novel Outreach Program and Practical Strategies for Patients with Parkinsonism in the COVID-19 Pandemic.

Authors:  Brianna Sennott; Katheryn Woo; Serena Hess; Daniela Mitchem; Ellen C Klostermann; Erica Myrick; Rodolfo Savica; Jori E Fleisher
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

4.  Peer Mentoring Program for Informal Caregivers of Homebound Individuals With Advanced Parkinson Disease (Share the Care): Protocol for a Single-Center, Crossover Pilot Study.

Authors:  Jori E Fleisher; Faizan Akram; Jeanette Lee; Ellen C Klostermann; Serena P Hess; Erica Myrick; Melissa Levin; Bichun Ouyang; Jayne Wilkinson; Deborah A Hall; Joshua Chodosh
Journal:  JMIR Res Protoc       Date:  2022-05-26

5.  Sex Differences in Parkinson's Disease: From Bench to Bedside.

Authors:  Maria Claudia Russillo; Valentina Andreozzi; Roberto Erro; Marina Picillo; Marianna Amboni; Sofia Cuoco; Paolo Barone; Maria Teresa Pellecchia
Journal:  Brain Sci       Date:  2022-07-13

6.  Factors associated with physical, psychological and social frailty among community-dwelling older persons in Europe: a cross-sectional study of Urban Health Centres Europe (UHCE).

Authors:  Lizhen Ye; Liset E M Elstgeest; Xuxi Zhang; Tamara Alhambra-Borrás; Siok Swan Tan; Hein Raat
Journal:  BMC Geriatr       Date:  2021-07-12       Impact factor: 3.921

Review 7.  Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention.

Authors:  Pavan A Vaswani; Thomas F Tropea; Nabila Dahodwala
Journal:  Neurotherapeutics       Date:  2020-11-04       Impact factor: 6.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.